Atlas Trials

Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication

Clinical trial NCT00102050 · COMPLETED

Trial details

NCT number
NCT00102050
Sponsor
Nissan Chemical Industries
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Intermittent ClaudicationPeripheral Vascular Disease
Start date
2003-04-01
Enrollment
390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.